Primary undifferentiated carcinoma of the small intestine: an immunohistochemical study and review of the literature

被引:0
作者
Tsutomu Namikawa
Michiya Kobayashi
Jun Iwabu
Hiroyuki Kitagawa
Hiromichi Maeda
Takehiro Okabayashi
Mitsuko Iguchi
Makoto Hiroi
Kazuhiro Hanazaki
机构
[1] Kochi Medical School,Department of Surgery
[2] Kochi Medical School,Department of Human Health and Medical Sciences
[3] Kochi Medical School Hospital,Laboratory of Diagnostic Pathology
来源
Medical Molecular Morphology | 2010年 / 43卷
关键词
Undifferentiated carcinoma; Anaplastic carcinoma; Small intestinal cancer; Immunohistochemistry; AE1/AE3; CAM5.2; Epithelial membrane antigen;
D O I
暂无
中图分类号
学科分类号
摘要
Primary undifferentiated carcinoma of the small intestine is an extremely rare neoplasm. Here, we report a case of primary undifferentiated carcinoma that arose from the ileum in a 65-year-old woman. Laboratory data revealed anemia and slightly elevated inflammatory parameters. Computed tomography showed a heterogeneous mass in the pelvic cavity, and magnetic resonance imaging revealed that the margin of the tumor mass was clear. Positron emission tomography using 18F-fluoro-2-deoxy-d-glucose (FDG) showed accumulation of FDG on the tumor mass with a standardized uptake value of 8.3. Partial resection of the ileum to remove the tumor was performed under a clinical diagnosis of small intestinal carcinoma. The tumor was nodulated and had a circumscribed margin 6.5 × 5.5 × 4 cm in diameter. Microscopically, the tumor was composed of giant polygonal cells with cellular atypia. Immunohistochemical examination revealed that the tumor cells expressed epithelial markers including AE1/AE3, CAM5.2, and EMA; however, lymphocytic, mesenchymal, and gastrointestinal stromal tumor markers were not expressed. We made a final diagnosis of primary undifferentiated carcinoma of the small intestine. The prognosis of patients with undifferentiated carcinoma of the small intestine is very poor. To improve the outcome of treatment, early and accurate diagnosis is essential, and additional therapy, including multimodality adjuvant therapy or the administration of novel molecular targeted drugs, should be considered.
引用
收藏
页码:91 / 95
页数:4
相关论文
共 158 条
[1]  
Silberman H.(1974)Neoplasms of the small bowel Ann Surg 180 157-161
[2]  
Crichlow R.W.(2009)Clinical analysis of primary anaplastic carcinoma of the small intestine World J Gastroenterol 15 526-530
[3]  
Caplan H.S.(1979)Primary carcinoma of the small intestine: a report of two cases J Hiroshima Med Assoc 27 358-362
[4]  
Namikawa T.(1988)A case of small intestinal undifferentiated carcinoma with a chief complaint of anemia Jpn J Gastroenterol Surg 21 2435-2438
[5]  
Hanazaki K.(1989)Anaplastic and sarcomatoid carcinoma of the small intestine: a clinicopathologic study Hum Pathol 20 858-863
[6]  
Ikeda Y.(1993)A case of primary ileal undifferentiated carcinoma: clinicopathological study on 95 cases of primary jejunal and ileal carcinoma in Japan Jpn J Surg Assoc 54 450-454
[7]  
Matsumura S.(1998)Two cases of primary small intestinal cancer J Hiroshima Med Assoc 51 739-742
[8]  
Sunagawa K.(1999)Anaplastic and sarcomatoid carcinoma of the small intestine: an unusual tumor J Clin Gastroenterol 29 99-101
[9]  
Watanabe K.(2000)A case of undifferentiated cancer with neuroendocrine differentiation of the small intestine accompanied by multiple small bowel metastases Jpn J Surg Assoc 61 3271-3275
[10]  
Masaoka T.(2003)A case of primary anaplastic carcinoma of the small intestine Jpn J Gastroenterol Surg 36 1615-1620